Beta-secretase

β-分泌酶 (BACE) 是一种跨膜天冬氨酸蛋白酶,负责裂解淀粉样蛋白前体 (APP) 以生成可溶性胞外域 sAPPbeta 及其 C 端片段 CTFbeta。BACE 是阿尔茨海默病 (AD) 治疗的主要靶点。该酶有两种形式:BACE1 和 BACE2。

淀粉样蛋白-β (Aβ) 沉积形成神经斑块是阿尔茨海默病 (AD) 的典型神经病理学。Aβ 由 APP 通过 β 和 γ-分泌酶裂解生成。BACE1 是 β-分泌酶,其抑制会引起严重的副作用,而其同源物 BACE2 通常通过在 Aβ 域内的 θ 位点 (Phe20) 裂解 APP/Aβ 来抑制 Aβ。

Beta-secretase (BACE) is a transmembrane aspartic proteinase responsible for cleaving the amyloid precursor protein (APP) to generate the soluble ectodomain sAPPbeta and its C-terminal fragment CTFbeta. BACE is a major target of Alzheimer's disease (AD) therapeutics. There are two forms of the enzyme: BACE1 and BACE2.

Deposition of amyloid-β protein (Aβ) to form neuritic plaques is the characteristic neuropathology of Alzheimer's disease (AD). Aβ is generated from APP by β- and γ-secretase cleavages. BACE1 is the β-secretase and its inhibition induces severe side effects, whereas its homolog BACE2 normally suppresses Aβ by cleaving APP/Aβ at the θ-site (Phe20) within the Aβ domain.

Beta-secretase亚型特异性产品:Beta-secretase Isoform Comparison
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(R)-Eslicarbazepine acetate
(R)-利卡西平乙酸酯; BIA 2-059; (R)-Licarbazepine acetate

(R)-Eslicarbazepine acetate (BIA 2-059) 是 Eslicarbazepine acetate (MS-X22556) 的 R-对映体,而 Eslicarbazepine acetate 是一种抗癫痫剂,可作为 β-分泌酶和电压门控钠通道的双重抑制剂。

186694-45-1
Control
(R)-利卡西平乙酸酯

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础